Day One Biopharmaceuticals
DAWN
DAWN
108 hedge funds and large institutions have $1.29B invested in Day One Biopharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 39 increasing their positions, 25 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.88% less ownership
Funds ownership: 82.72% → 81.84% (-0.88%)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
33% less call options, than puts
Call options by funds: $2.98M | Put options by funds: $4.43M
Holders
108
Holding in Top 10
4
Calls
$2.98M
Puts
$4.43M
Top Buyers
| 1 | +$12.8M | |
| 2 | +$10.6M | |
| 3 | +$10.2M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$9.93M |
| 5 |
State Street
Boston,
Massachusetts
|
+$8.93M |
Top Sellers
| 1 | -$95M | |
| 2 | -$12.9M | |
| 3 | -$8.01M | |
| 4 |
BlackRock
New York
|
-$2.28M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$1.77M |